Discover how the S&P 500 Index performed in 2024 and what that could mean for the first quarter of 2025 according to Barclays ...

Investment firm Barclays laid out its thoughts for the technology space in 2025 in a research note on Thursday, covering ...

Barclays Plc’s Stephen Dainton is preparing for a wave of dealmaking this year as more US companies have been buoyed by ...

Emmanuel Cau, head of European equity strategy at Barclays, weighs in on the outlook for European stocks in 2025.

Barclays PLC BARC shares slid 2.60% to £2.66 Tuesday, on what proved to be an all-around grim trading session for the stock ...

Financial analysts at Barclays have upgraded Boeing (BA) to Overweight, citing improved balance sheet, higher free cash flow, ...

BTS member J-Hope reveals his first-ever solo tour, hitting venues in 2025 in North America and Asia for Hope on the Stage ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

In a report released today, Seth Sigman from Barclays maintained a Hold rating on Five Below (FIVE – Research Report), with a price target of ...

The scrooges at Barclays canned 15 Wall Street workers out of the roughly 50 it pink-slipped last month, two sources with ...

Analysts at London-based multinational bank Barclays are speculating that Boeing’s stocks could be on the uptick to recovery ...

On Wednesday, Barclays PLC (BCS) stock saw a decline, ending the day at $13.19 which represents a decrease of $-0.06 or -0.45% from the prior close of $13.25. The stock opened at $13.01 and touched a ...